NYSE:JNJ - Johnson & Johnson News Headlines

Sign in or create an account to add this stock to your watchlist.
$140.47 -2.41 (-1.69 %)
(As of 09/24/2018 04:00 PM ET)
Previous Close$142.88
Today's Range$140.23 - $142.45
52-Week Range$118.62 - $148.32
Volume530,060 shs
Average Volume5.66 million shs
Market Capitalization$383.33 billion
P/E Ratio19.44
Dividend Yield2.52%
Beta0.69

Headlines

Johnson & Johnson (NYSE JNJ) News Headlines

Source:
DateHeadline
Johnson & Johnson Vision präsentiert die neuesten klinischen Daten und Augenpflegelösungen auf der ESCRS Jahrestagung 2018Johnson & Johnson Vision präsentiert die neuesten klinischen Daten und Augenpflegelösungen auf der ESCRS Jahrestagung 2018
www.prnewswire.com - September 22 at 11:31 AM
Johnson & Johnson Vision muestra datos clínicos y soluciones de tratamiento oftalmológico en la reunión ESCRS 2018Johnson & Johnson Vision muestra datos clínicos y soluciones de tratamiento oftalmológico en la reunión ESCRS 2018
www.prnewswire.com - September 22 at 11:31 AM
Boston Scientific, Edwards Lifesciences May Tempt J&JBoston Scientific, Edwards Lifesciences May Tempt J&J
finance.yahoo.com - September 22 at 8:09 AM
There Is A More Important Question Than High P/E Ratios Affecting Dividends: Johnson & JohnsonThere Is A More Important Question Than High P/E Ratios Affecting Dividends: Johnson & Johnson
seekingalpha.com - September 21 at 5:00 PM
Johnson & Johnson Vision Showcases Latest Clinical Data and Eye Care Solutions at the ESCRS 2018 Annual MeetingJohnson & Johnson Vision Showcases Latest Clinical Data and Eye Care Solutions at the ESCRS 2018 Annual Meeting
www.prnewswire.com - September 21 at 8:11 AM
Johnson & Johnson Vision представляет новейшие клинические данные и решения для ухода за здоровьем глаз на ежегодном конгрессе ESCRS 2018Johnson & Johnson Vision представляет новейшие клинические данные и решения для ухода за здоровьем глаз на ежегодном конгрессе ESCRS 2018
www.prnewswire.com - September 21 at 4:58 AM
Johnson & Johnson to Host Investor Conference Call on Third-Quarter ResultsJohnson & Johnson to Host Investor Conference Call on Third-Quarter Results
finance.yahoo.com - September 19 at 5:48 PM
Janssen (JNJ) Submits NDA to FDA Seeking Approval of Erdafitinib for Treatment of Metastatic UCJanssen (JNJ) Submits NDA to FDA Seeking Approval of Erdafitinib for Treatment of Metastatic UC
www.streetinsider.com - September 19 at 8:14 AM
Exclusive - India, U.S. closing in on package deal to remove trade irritantsExclusive - India, U.S. closing in on package deal to remove trade irritants
finance.yahoo.com - September 18 at 8:12 AM
Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates AgainWhy Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again
finance.yahoo.com - September 17 at 5:23 PM
Zacks: Analysts Anticipate Johnson & Johnson (JNJ) Will Post Quarterly Sales of $19.91 BillionZacks: Analysts Anticipate Johnson & Johnson (JNJ) Will Post Quarterly Sales of $19.91 Billion
www.americanbankingnews.com - September 16 at 12:57 PM
Wall Street Analysts Are Mostly Positive on Merck in SeptemberWall Street Analysts Are Mostly Positive on Merck in September
finance.yahoo.com - September 15 at 8:12 AM
$2.03 EPS Expected for Johnson & Johnson (JNJ) This Quarter$2.03 EPS Expected for Johnson & Johnson (JNJ) This Quarter
www.americanbankingnews.com - September 14 at 10:10 PM
Johnson & Johnson Medical GmbH Acquires Emerging Implant Technologies GmbH to Enhance Global Offering of ...Johnson & Johnson Medical GmbH Acquires Emerging Implant Technologies GmbH to Enhance Global Offering of ...
www.prnewswire.com - September 14 at 5:07 PM
Johnson & Johnson To Present At Morgan Stanley Conference; Webcast At 9:55 AM ETJohnson & Johnson To Present At Morgan Stanley Conference; Webcast At 9:55 AM ET
www.nasdaq.com - September 14 at 5:07 PM
Johnson & Johnson sees "above-market" growth in pharma unit for next three yearsJohnson & Johnson sees "above-market" growth in pharma unit for next three years
seekingalpha.com - September 14 at 5:07 PM
Johnson & Johnson (JNJ) Pharmaceutical Business Review Conference (Transcript)Johnson & Johnson (JNJ) Pharmaceutical Business Review Conference (Transcript)
seekingalpha.com - September 14 at 5:07 PM
Johnson & Johnson (JNJ) Rating Reiterated by Wells Fargo & CoJohnson & Johnson (JNJ) Rating Reiterated by Wells Fargo & Co
www.americanbankingnews.com - September 14 at 1:07 PM
Johnson & Johnson Expands Blood Cancer Portfolio with ApprovalJohnson & Johnson Expands Blood Cancer Portfolio with Approval
finance.yahoo.com - September 14 at 8:15 AM
Johnson & Johnson Medical GmbH Acquires Emerging Implant Technologies GmbH to Enhance Global Offering of Interbody Spine ImplantsJohnson & Johnson Medical GmbH Acquires Emerging Implant Technologies GmbH to Enhance Global Offering of Interbody Spine Implants
www.marketwatch.com - September 12 at 4:56 PM
Ronald A. Kapusta Sells 7,899 Shares of Johnson & Johnson (JNJ) StockRonald A. Kapusta Sells 7,899 Shares of Johnson & Johnson (JNJ) Stock
www.americanbankingnews.com - September 11 at 7:40 PM
Johnson & Johnson: Where Is The Path To Gains?Johnson & Johnson: Where Is The Path To Gains?
seekingalpha.com - September 11 at 5:00 PM
Alcon to Set Up Future Global Headquarters in GenevaAlcon to Set Up Future Global Headquarters in Geneva
finance.yahoo.com - September 11 at 5:00 PM
See How Johnson & Johnson Ranks Among Analysts Top Dow 30 PicksSee How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks
www.nasdaq.com - September 10 at 5:02 PM
Johnson & Johnson says to work on India compensation for recalled hip implantsJohnson & Johnson says to work on India compensation for recalled hip implants
www.reuters.com - September 7 at 8:11 AM
Johnson & Johnson (JNJ) Management Presents at Barclays Global Consumer Staples Conference Call (Transcript)Johnson & Johnson (JNJ) Management Presents at Barclays Global Consumer Staples Conference Call (Transcript)
seekingalpha.com - September 7 at 8:11 AM
How Tesaro Hopes to Tackle Lung CancerHow Tesaro Hopes to Tackle Lung Cancer
finance.yahoo.com - September 7 at 8:11 AM
Johnson & Johnson To Present At Barclays Conference; Webcast At 12:45Johnson & Johnson To Present At Barclays Conference; Webcast At 12:45
www.nasdaq.com - September 6 at 5:12 PM
Johnson & Johnson (JNJ) CEO Alex Gorsky Presents at 2018 Wells Fargo 13th Annual Healthcare Conference (Transcript)Johnson & Johnson (JNJ) CEO Alex Gorsky Presents at 2018 Wells Fargo 13th Annual Healthcare Conference (Transcript)
seekingalpha.com - September 6 at 5:12 PM
Recent Product Approvals Bode Well for Intuitive SurgicalRecent Product Approvals Bode Well for Intuitive Surgical
finance.yahoo.com - September 6 at 5:12 PM
J&J (JNJ) Says Job Posting Not Related to Decision on Pact with Geron (GERN) - BloombergJ&J (JNJ) Says Job Posting Not Related to Decision on Pact with Geron (GERN) - Bloomberg
www.streetinsider.com - September 5 at 8:10 AM
Johnson & Johnson files U.S. marketing application for esketamine nasal spray for depressionJohnson & Johnson files U.S. marketing application for esketamine nasal spray for depression
seekingalpha.com - September 4 at 5:13 PM
Johnson & Johnson (JNJ) Receives Consensus Rating of "Hold" from AnalystsJohnson & Johnson (JNJ) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - September 3 at 4:34 AM
Dividend Champion Spotlight: Johnson & JohnsonDividend Champion Spotlight: Johnson & Johnson
seekingalpha.com - September 2 at 6:05 PM
[$$] Johnson & Johnson Heads Health Care List in Management Top 250[$$] Johnson & Johnson Heads Health Care List in Management Top 250
finance.yahoo.com - August 31 at 5:23 PM
Johnson & Johnsons Oncology Segment Will Likely See Strong Growth In The Near TermJohnson & Johnson's Oncology Segment Will Likely See Strong Growth In The Near Term
www.forbes.com - August 31 at 1:31 PM
Pfizer’s Quarterly Revenues and Estimates for 2018Pfizer’s Quarterly Revenues and Estimates for 2018
finance.yahoo.com - August 30 at 5:29 PM
Better Buy: Johnson & Johnson vs. MerckBetter Buy: Johnson & Johnson vs. Merck
finance.yahoo.com - August 30 at 8:17 AM
Morning News Call - India, August 30Morning News Call - India, August 30
finance.yahoo.com - August 30 at 8:17 AM
 Brokerages Anticipate Johnson & Johnson (JNJ) Will Announce Quarterly Sales of $19.91 Billion Brokerages Anticipate Johnson & Johnson (JNJ) Will Announce Quarterly Sales of $19.91 Billion
www.americanbankingnews.com - August 30 at 1:40 AM
3 ETFs for Johnson & Johnsons Healthy Breakout3 ETFs for Johnson & Johnson's Healthy Breakout
www.investopedia.com - August 29 at 8:14 AM
[$$] Portola Pharmaceuticals Director Scores With Stock Purchase[$$] Portola Pharmaceuticals Director Scores With Stock Purchase
finance.yahoo.com - August 29 at 8:14 AM
Dow Movers: JNJ, DWDPDow Movers: JNJ, DWDP
www.nasdaq.com - August 28 at 5:03 PM
Johnson & Johnson (JNJ) Updates on Mariner & Commander HF Clinical Trial Results - SlideshowJohnson & Johnson (JNJ) Updates on Mariner & Commander HF Clinical Trial Results - Slideshow
seekingalpha.com - August 28 at 5:03 PM
Johnson & Johnson Is Hiring -- and Its Ginormous News for GeronJohnson & Johnson Is Hiring -- and It's Ginormous News for Geron
www.fool.com - August 28 at 9:34 AM
[$$] Big pharma takes a gamble on NHS experiment[$$] Big pharma takes a gamble on NHS experiment
finance.yahoo.com - August 28 at 8:09 AM
Johnson & Johnson to Participate in the 2018 Morgan Stanley 16th Annual Global Healthcare ConferenceJohnson & Johnson to Participate in the 2018 Morgan Stanley 16th Annual Global Healthcare Conference
www.marketwatch.com - August 27 at 5:18 PM
UPDATE: Johnson & Johnson to Host Investor Conference Call on the Pharmaceutical BusinessUPDATE: Johnson & Johnson to Host Investor Conference Call on the Pharmaceutical Business
finance.yahoo.com - August 27 at 5:18 PM
Johnson & Johnson to host conference call on the phase 3 MARINER and COMMANDER HF studies for XARELTOJohnson & Johnson to host conference call on the phase 3 MARINER and COMMANDER HF studies for XARELTO
seekingalpha.com - August 27 at 8:09 AM
Johnson & Johnson May Rise 9% on Better GrowthJohnson & Johnson May Rise 9% on Better Growth
finance.yahoo.com - August 27 at 8:09 AM
This page was last updated on 9/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel